We are live on
!
Find out more
HI
HBK Investments Portfolio holdings
AUM
$9.85B
1-Year Est. Return
55.6%
This Fund
S&P 500
This Quarter
Est. Return
+17.33%
1 Year Est. Return
+55.6%
3 Year Est. Return
+156.38%
5 Year Est. Return
+423.64%
10 Year Est. Return
+2,347.17%
AUM
$10.4B
AUM Growth
+$2.53B
(+32%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
12.67%
Top 10 Holdings %
Top 10 Hldgs %
59.14%
Holding
804
New
199
Increased
164
Reduced
169
Closed
151
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CZR
Caesars Entertainment Corporation
CZR
|
+$367M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$259M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$109M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$86.7M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$71.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.57B |
| 2 |
Petrobras Class A
PBR.A
|
+$103M |
| 3 |
Takeda Pharmaceutical
TAK
|
+$45.4M |
| 4 |
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
|
+$25.2M |
| 5 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6% |
| 2 | Consumer Discretionary | 5.59% |
| 3 | Financials | 2.1% |
| 4 | Communication Services | 0.8% |
| 5 | Healthcare | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
PUT
Regeneron Pharmaceuticals
REGN
$80.8B
| $2.4M | 0.02% |
6,400
+4,000
| +167% | +$1.35M |
|
377
Lockheed Martin
LMT
$136B
| $2.34M | 0.02% |
+6,017
| New | +$2.31M |
|
378
Sonos
SONO
$1.85B
| $2.34M | 0.02% |
150,000
-50,000
| -25% | -$697K |
|
379
CALL
Encore Capital Group
ECPG
$2.13B
| $2.33M | 0.02% |
+66,000
| New | +$2.31M |
|
380
Texas Instruments
TXN
$261B
| $2.32M | 0.02% |
18,064
+1,077
| +6% | +$133K |
|
|
RSX
381
DELISTED
VanEck Russia ETF
RSX
| $2.31M | 0.02% |
92,691
-55,500
| -37% | -$1.35M |
|
382
United Airlines
UAL
$42.1B
| $2.26M | 0.02% |
25,649
+11,198
| +77% | +$1.01M |
|
383
CALL
PACCAR
PCAR
$70.1B
| $2.25M | 0.02% |
+42,750
| New | +$2.2M |
|
|
384
PUT
PACCAR
PCAR
$70.1B
| $2.25M | 0.02% |
+42,750
| New | +$2.2M |
|
385
CALL
Molson Coors Class B
TAP
$8.09B
| $2.23M | 0.02% |
41,400
| – | – |
|
|
386
PUT
Molson Coors Class B
TAP
$8.09B
| $2.23M | 0.02% |
41,400
| – | – |
|
387
Baker Hughes
BKR
$61.1B
| $2.22M | 0.02% |
+86,667
| New | +$1.97M |
|
|
ABMD
388
CALL
DELISTED
Abiomed Inc
ABMD
| $2.22M | 0.02% |
+13,000
| New | +$2.41M |
|
|
ABMD
389
PUT
DELISTED
Abiomed Inc
ABMD
| $2.22M | 0.02% |
+13,000
| New | +$2.41M |
|
390
PUT
T. Rowe Price
TROW
$24.3B
| $2.22M | 0.02% |
18,200
| – | – |
|
391
CALL
Capri Holdings
CPRI
$1.74B
| $2.2M | 0.02% |
57,700
+4,900
| +9% | +$169K |
|
|
392
PUT
Capri Holdings
CPRI
$1.74B
| $2.2M | 0.02% |
57,700
+4,900
| +9% | +$169K |
|
393
Sprout Social
SPT
$621M
| $2.18M | 0.02% |
+136,018
| New | +$2.21M |
|
|
XLNX
394
CALL
DELISTED
Xilinx Inc
XLNX
| $2.17M | 0.02% |
22,200
-3,600
| -14% | -$338K |
|
|
XLNX
395
PUT
DELISTED
Xilinx Inc
XLNX
| $2.17M | 0.02% |
22,200
-3,600
| -14% | -$338K |
|
|
SWT
396
DELISTED
Stanley Black & Decker, Inc.
SWT
| $2.16M | 0.02% |
+20,000
| New | +$2.11M |
|
|
PXD
397
DELISTED
Pioneer Natural Resource Co.
PXD
| $2.12M | 0.02% |
+13,993
| New | +$1.86M |
|
398
CALL
Delta Air Lines
DAL
$60.1B
| $2.09M | 0.02% |
35,700
-4,000
| -10% | -$224K |
|
399
CALL
NetApp
NTAP
$37.2B
| $2.08M | 0.02% |
33,400
+6,600
| +25% | +$385K |
|
|
400
PUT
NetApp
NTAP
$37.2B
| $2.08M | 0.02% |
33,400
+6,600
| +25% | +$385K |
|
Similar funds
MF
MPI
URS
CCM
HRCM
FCM
HL
DCP
HBK Investments's Q4 2019 Portfolio in Review
As of Q4 2019, HBK Investments held 804 positions worth $10.4B, up 32% from $7.82B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
HBK Investments deployed $1.31B of net new capital in Q4 2019, opening 199 new positions and adding to 164 existing holdings. Its largest new stake was Medicines Co: 3,880,000 shares worth $330M.
By sector, the portfolio is most concentrated in Technology at 6% of assets, down from 6.8% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Liberty Media Corporation Series A Liberty SiriusXM Common Stock, an estimated $25.2M trimmed.
- HBK Investments's largest Q4 2019 buy was Medicines Co: 3,880,000 shares worth $330M.
- HBK Investments added most to Caesars Entertainment Corporation in Q4 2019, an estimated $367M increase.
- HBK Investments's biggest Q4 2019 reduction was Liberty Media Corporation Series A Liberty SiriusXM Common Stock, cutting an estimated $25.2M.
- HBK Investments fully exited Celgene Corp in Q4 2019, selling an estimated $1.57B.
- HBK Investments's ten largest holdings make up 59% of its $10.4B portfolio in Q4 2019.
- HBK Investments opened 199 new positions and closed 151 in Q4 2019.
- HBK Investments's portfolio value rose 32% quarter-over-quarter to $10.4B.
Based on HBK Investments's 13F filing for Q4 2019, filed 14 Feb 2020.